|
|
||||||||
Ann Thorac Surg 2004;78:1965-1971
© 2004 The Society of Thoracic Surgeons
Department of Cardiovascular Surgery and Pediatric Cardiology, Fukuoka Children's Hospital Medical Center, Fukuoka, Japan
Accepted for publication June 2, 2004.
* Address reprint requests to Dr Tanoue, Department of Cardiovascular Surgery, Kyushu University, 311 Maidashi, Higashi-ku, Fukuoka 8128582, Japan (E-mail: tanoue{at}heart.med.kyushu-u.ac.jp).
| Abstract |
|---|
|
|
|---|
METHODS: Twenty-one patients who underwent both a bidirectional Glenn procedure and a total cavopulmonary connection after Norwood palliation at Fukuoka Children's Hospital Medical Center were divided into two groups: the systemicpulmonary shunt group (n = 11) and the right ventricularpulmonary artery conduit group (n = 10). End-systolic elastance (contractility), effective arterial elastance (afterload), and ventriculoarterial coupling and the ratio of stroke work and pressure-volume area (ventricular efficiency) were measured on the basis of cardiac catheterization data before the bidirectional Glenn procedure, before and after the total cavopulmonary connection, and at approximately 1 year after total cavopulmonary connection.
RESULTS: After bidirectional Glenn procedure and total cavopulmonary connection, end-systolic elastance of the right ventricularpulmonary artery conduit group was lower than that of the systemicpulmonary shunt group, whereas effective arterial elastance of the right ventricularpulmonary artery conduit group was lower than that of the systemicpulmonary shunt group. Consequently, there was no difference in ventricular efficiency in both groups 1 year after total cavopulmonary connection.
CONCLUSIONS: The midterm ventricular performance of the right ventricularpulmonary artery conduit group was comparable with the systemicpulmonary shunt group in terms of ventricular efficiency. However, after bidirectional Glenn procedure and total cavopulmonary connection, contractility in patients who underwent a Norwood procedure with a right ventricularpulmonary artery conduit was inferior to that of patients who underwent a Norwood procedure with a systemicpulmonary shunt.
| Introduction |
|---|
|
|
|---|
In the present study, we compared the ventricular performance after the bidirectional Glenn procedure (BDG) and a total cavopulmonary connection (TCPC) in HLHS patients who underwent Norwood RVPA and Norwood SP. The purpose of this study was to analyze the midterm (1 year after TCPC) ventricular performance (contractility, afterload, ventricular efficiency) of HLHS patients who had undergone Norwood RVPA.
| Patients and Methods |
|---|
|
|
|---|
In the SP group, mean ages of all patients were 14.4 ± 5.6 days (range, 6 to 26 days) for Norwood palliation, 13.4 ± 8.1 months (range, 6 to 28 months) for BDG, and 35.8 ± 11.9 months (range, 17 to 58 months) for TCPC. Mean weights were 2.76 ± 0.23 kg (range, 2.44 to 3.20 kg) for Norwood palliation, 6.71 ± 1.59 kg (range, 4.44 to 9.05 kg) for BDG, and 11.10 ± 1.89 kg (range, 8.06 to 14.80 kg) for TCPC. In the RVPA group, mean ages of all patients were 14.9 ± 6.8 days (range, 7 to 25 days) for Norwood palliation, 7.0 ± 2.1 months (range, 4 to 11 months) for BDG (p = 0.0267 versus the SP group by Student's unpaired t test), and 24.2 ± 4.7 months (range, 17 to 32 months) for TCPC (p = 0.0095 versus the SP group). The mean weight was 2.87 ± 0.47 kg (range, 1.72 to 3.42 kg) for Norwood palliation, 5.86 ± 0.85 kg (range, 4.82 to 7.63 kg) for BDG, and 10.06 ± 0.86 kg (range, 8.92 to 11.40 kg) for TCPC.
Operative Techniques
All operations were performed by the same cardiac surgeon (H.K.). Anesthesia was done using a standard technique with intravenous infusion of fentanyl, inhalation of sevoflurane, and muscle relaxation with pancuronium. The descending aorta cannulation technique combined with innominate artery perfusion and bicaval cannulations were performed thorough a standard median sternotomy [14, 15]. Cardiopulmonary bypass was instituted by a heart-lung machine consisting of a rotating pump and a membrane oxygenator. Circulatory arrest was avoided, and myocardial preservation was achieved using cold crystalloid cardioplegic solution [16, 17] combined with topical cooling.
NORWOOD PALLIATION
Norwood SP was performed in 11 patients (SP group), using a 3.5-mm polytetrafluoroethylene graft in 8 patients and a 4-mm polytetrafluoroethylene graft in 3 patients [15]. Norwood RVPA was performed in 10 patients (RVPA group), using a 5-mm polytetrafluoroethylene graft in 4 patients and a 6-mm polytetrafluoroethylene graft in 6 patients [9, 10]. The mean diameters of the ascending aorta were 3.0 ± 1.1 mm (range, 2.0 to 5.0 mm) in the SP group and 3.2 ± 1.6 mm (range, 2.0 to 6.0 mm) in the RVPA group. Regarding concomitant procedures, tricuspid valvuloplasty was performed in 3 patients of the RVPA group (no patient in the SP group).
BIDIRECTIONAL GLENN PROCEDURE
A bidirectional cavopulmonary shunt was made by direct end-to-side anastomosis between the superior vena cava and the pulmonary artery. Bilateral superior venae cavae were present in 2 children of the RVPA group, and bidirectional cavopulmonary anastomoses were done in a separate fashion. Regarding concomitant procedures, tricuspid valvuloplasty was performed in 5 patients (2 in the SP group and 3 in the RVPA group), an augmentation of the pulmonary artery was performed in 10 patients (5 from each group), an enlargement of atrial septal defect was performed in 3 in the RVPA group, and plasty of the aorta was performed in 3 in the SP group. Additional pulmonary blood flow was maintained in 8 patients in the RVPA group.
TOTAL CAVOPULMONARY CONNECTION
For inferior cavopulmonary anastomosis, the extracardiac conduit approach using a 16- to 18-mm polytetrafluoroethylene graft [18] was performed in all patients. Fenestration was created in 4 (1 in the SP group and 3 in the RVPA group). Regarding concomitant procedures, tricuspid valvuloplasty was performed in 6 (3 from each group), augmentation of the pulmonary artery was performed in 6 (1 in the SP group and 5 in the RVPA group), and an enlargement of atrial septal defect was performed in 1 in the SP group.
Data Analysis
All patients underwent cardiac catheterization before BDG, before TCPC, and after TCPC, and 16 patients (9 in the SP group and 7 in the RVPA group) underwent cardiac catheterization at approximately 1 year after TCPC. The right ventricular (RV) volume was calculated according to Simpson's rule [19]. The calculation of the percent normal RV end-diastolic volume was based on the control data of patients who underwent follow-up cardiac catheterization after Kawasaki's disease with intact coronary artery at Fukuoka Children's Hospital Medical Center. The RV ejection fraction was calculated as follows: ejection fraction = (1 minimal RV volume/maximal RV volume) x100 (%). The calculations of contractility (end-systolic elastance; Ees), afterload (effective arterial elastance; Ea), and ventricular efficiency (ventriculoarterial coupling; Ea/Ees, and the ratio of stroke work and pressure-volume area; SW/PVA) were performed based on the pressure and volume data of cardiac catheterization by the approximation method as previously described [2022]. The approximation of Ees and Ea was performed as follows: Ees = mean arterial pressure/minimal RV volume, and Ea = maximal RV pressure/(maximal RV volume minimal RV volume). The ventricular volume was divided by the body surface area. The ratio of Ea to Ees (Ea/Ees) and SW/PVA were calculated as indices of ventricular efficiency. The ratio Ea/Ees is the ventriculoarterial coupling between the left ventricle and the arterial system described by Burkhoff and Sagawa [23]. The SW/PVA was calculated as follows: SW/PVA = 1/(1 + 0.5Ea/Ees) x100 (%). This theoretical formula has previously been described by Nozawa and associates [24].
Statistical Analysis
The results are presented as mean ± standard deviation. Two-factor analysis of variance with repeated measures on one factor was used for the variables measured at four points (before BDG, before TCPC, after TCPC, and 1 year after TCPC). Student-Newman-Keuls test was used as a post hoc test.
| Results |
|---|
|
|
|---|
|
|
| Comment |
|---|
|
|
|---|
In our hospital, several strategies have been initiated to improve the clinical results of HLHS patients. The following strategies are pursued: (1) the complete avoidance of circulatory arrest throughout the Norwood procedure (the descending aorta cannulation technique combined with the innominate artery perfusion) [14, 15]; (2) the construction of a neoaorta without the use of any patching material [10, 15]; (3) a nonvalved RVPA conduit instead of a systemicpulmonary shunt for the prevention of hemodynamic instability [10]; and (4) a staged Fontan procedure with an extracardiac conduit under a beating heart in right heart bypass surgery [26, 27]. These various strategies have improved clinical outcomes for HLHS patients in our hospital. The excellent hemodynamic stability provided after Norwood RVPA would be one of the most important factors for obtaining the improvement in clinical results.
Norwood RVPA was recently accepted as a new operative strategy for the management of HLHS patients [912] and provides a stable systemic circulation with adequate pulmonary blood flow, as well as improves coronary perfusion. On the other hand, the influence of an incision in the right ventricle for the placement of the RVPA conduit and diastolic regurgitation through the conduit on systemic RV function are of great concern. Systemic RV function after Norwood RVPA evaluated by echocardiography or cardiac catheterization was reported to be acceptable [11, 12]. In the present study, systemic RV performance (Ees, Ea, Ea/Ees, and SW/PVA) of the RVPA group was comparable with that of the SP group after Norwood palliation (before BDG), but contractility (Ees) of the RVPA group was inferior to that of the SP group after BDG and TCPC. The size of the RVPA conduit used was 5 mm in patients weighing less than 3 kg and 6 mm in the other patients in our hospital. There is no difference in RV performance and incidence of tricuspid regurgitation between patients receiving 5-mm conduits and those receiving 6-mm conduits in this study. The decline in contractility, however, would imply some influence from the ventriculotomy on systolic RV function.
It is not sufficient to assess the systemic morphologic RV function by measuring ordinary hemodynamic variables alone. In the present study, mean aortic pressure and ejection fraction did not significantly change before and after BDG and TCPC, and the difference between the two groups did not reach statistical significance. In contrast, the change and difference of the load-independent variables of systolic ventricular function, Ees, the factor of afterload, Ea, and the indices of ventricular efficiency, Ea/Ees and SW/PVA, were dramatic. We previously reported the approximation of Ees and Ea, and validated this approximation using a canine right-heart bypass model with a conductance catheter [21]. We combined this approximation of the Ees and Ea with the cardiac catheterization data of single-ventricle patients, and then compared the ventricular performance of the patients who underwent right heart bypass surgery [20, 21]. We then reported the minimization of the afterload mismatch by cavopulmonary anastomosis on TCPC [21], and the correction of the afterload mismatch during the interval between BDG and staged TCPC [20]. With this simple approximation of Ees and Ea, the systolic morphologic RV contractility, afterload, and efficiency of HLHS patients could be evaluated from the conventional cardiac catheterization data in the present study. The Ea of the RVPA group was lower than that of the SP group although the Ees of the RVPA group was inferior to that of the SP group after BDG and TCPC. Consequently, Ea/Ees and SW/PVA of the RVPA group were comparable with those of the SP group. It is conceivable that the overall systemic RV performance of the RVPA group is acceptable in the midterm period.
The large percent normal RV end-diastolic volume after BDG and TCPC of the RVPA group could be caused by volume overload by the additional pulmonary blood flow. The RVPA conduit was left open to increase the oxygen saturation level and to promote pulmonary artery growth, and the additional flow was adjusted to elevate the superior vena cava pressure by 1 mm Hg. Although the role of the accessory pulmonary blood flow after BDG remains unclear [28], both pulmonary arterial index and systemic arterial oxygen saturation after the Norwood procedure (before BDG) of the RVPA group were lower than those of the SP group. The additional pulmonary blood flow is considered to be necessary for the children who underwent the Norwood RVPA to avoid any problems from desaturation. One year after TCPC, the contractility of the RVPA group was inferior to that of the SP group, although ventricular efficiency of the RVPA group was comparable with that of the SP group. The long-term follow-up of RV performance in HLHS patients who underwent Norwood RVPA is of critical importance.
The improvement in ventricular efficiency of the RVPA group during the 1-year period after TCPC was related not only to the improvement of contractility but also to the reduction of afterload. Afterload-reducing therapies help to improve ventricular performance in HLHS patients. Long-term oral intake of angiotensin-converting enzyme inhibitor or ß-adrenergic blocker is adopted in our hospital. Home oxygen therapy is also performed for at least 6 months after the operation to decrease pulmonary vascular resistance. Furthermore, we have adopted the permanent use of anticoagulation with warfarin sulfate to prevent thromboembolism. We hope that this anticoagulant therapy prevents microembolism in peripheral vessels and also suppresses any increase in afterload.
The approximation of Ees and Ea described in this study has so far only been validated in an animal model [21], and does not amount to the measurement by a conductance catheter. The validation of this approximation should therefore not only be performed on normal hearts but also on diseased hearts in human studies. However, the present approximation enables us to evaluate contractility, afterload, and ventricular efficiency from the conventional cardiac catheterization data [2022]. Correlation of tricuspid regurgitation and RV function should be analyzed. There is no difference in RV performance between the patients who required tricuspid valve repair or not throughout the assessment period. However, we cannot fully resolve this problem owing to the small number of patients. The influence of the RVPA conduit size and the additional pulmonary blood flow after BDG also should be weighed. However, this analysis also could not be performed in this paper because of the small number of patients. The sufficiency of the 16- to 18-mm extracardiac conduit after growth remains unclear. We think that more than a 16-mm conduit can be applicable and that good long-term results can be expected. There is no case of the conduit replacement after TCPC with extracardiac conduit in our hospital [27]. Finally, the long-term changes of Ees, Ea, Ea/Ees, and SW/PVA will be the next interesting problem. Further studies of the long-term period after TCPC in HLHS patients are thus called for.
In conclusion, the midterm results of Norwood RVPA are comparable with those of Norwood SP in terms of ventricular efficiency. However, after BDG and TCPC, the contractility of patients who underwent Norwood RVPA is inferior to that of patients who underwent Norwood SP, whereas the afterload of patients who underwent Norwood RVPA is lower than that of patients who underwent Norwood SP. Further evaluations of patients who undergo Norwood RVPA are thus called for to improve the long-term outcome of HLHS patients.
|
|
| References |
|---|
|
|
|---|
Related Article
This article has been cited by other articles:
![]() |
R. G. Ohye, J. W. Gaynor, N. S. Ghanayem, C. S. Goldberg, P. C. Laussen, P. C. Frommelt, J. W. Newburger, G. D. Pearson, S. Tabbutt, G. Wernovsky, et al. Design and rationale of a randomized trial comparing the Blalock-Taussig and right ventricle-pulmonary artery shunts in the Norwood procedure. J. Thorac. Cardiovasc. Surg., October 1, 2008; 136(4): 968 - 975. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Scheurer, J. W. Salvin, V. L. Vida, F. Fynn-Thompson, E. A. Bacha, F. A. Pigula, J. E. Mayer Jr, P. J. del Nido, D. L. Wessel, P. C. Laussen, et al. Survival and clinical course at fontan after stage one palliation with either a modified blalock-taussig shunt or a right ventricle to pulmonary artery conduit. J. Am. Coll. Cardiol., July 1, 2008; 52(1): 52 - 59. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Ballweg, T. E. Dominguez, C. Ravishankar, J. Kreutzer, B. S. Marino, G. L. Bird, P. J. Gruber, G. Wernovsky, J. W. Gaynor, S. C. Nicolson, et al. A contemporary comparison of the effect of shunt type in hypoplastic left heart syndrome on the hemodynamics and outcome at stage 2 reconstruction J. Thorac. Cardiovasc. Surg., August 1, 2007; 134(2): 297 - 303. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Tanoue, H. Kado, N. Boku, H. Tatewaki, T. Nakano, K. Fukae, M. Masuda, and R. Tominaga Three hundred and thirty-three experiences with the bidirectional Glenn procedure in a single institute Interactive CardioVascular and Thoracic Surgery, February 1, 2007; 6(1): 97 - 101. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Booth Surgical Outcome for Hypoplastic Left Heart Syndrome AAP Grand Rounds, September 1, 2006; 16(3): 29 - 30. [Full Text] [PDF] |
||||
![]() |
K. Takeuchi, A. Murakami, T. Takaoka, and S. Takamoto Evaluation of valved saphenous vein homograft as right ventricle-pulmonary artery conduit in modified stage I Norwood operation Interactive CardioVascular and Thoracic Surgery, August 1, 2006; 5(4): 345 - 348. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. D. Myers, K. Mattix, R. G. Presson Jr, P. Vijay, D. Maynes, K. N. Litwak, J. W. Brown, and M. D. Rodefeld Twenty-Four Hour Cardiopulmonary Stability in a Model of Assisted Newborn Fontan Circulation Ann. Thorac. Surg., January 1, 2006; 81(1): 264 - 271. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Tabbutt, T. E. Dominguez, C. Ravishankar, B. S. Marino, P. J. Gruber, G. Wernovsky, J. W. Gaynor, S. C. Nicolson, and T. L. Spray Outcomes After the Stage I Reconstruction Comparing the Right Ventricular to Pulmonary Artery Conduit With the Modified Blalock Taussig Shunt Ann. Thorac. Surg., November 1, 2005; 80(5): 1582 - 1591. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. P. Graham Jr The Year in Congenital Heart Disease J. Am. Coll. Cardiol., June 7, 2005; 45(11): 1887 - 1899. [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |